Dr Paul Nathan

Dr Paul Nathan

MB BS

Oncology

26 years of experience
18 years as a specialist

Overall Rating

Overall Experience

5

Bedside Manner

5

Explanation

5

Top feedback

“Dr Nathan is exemplary both in his medical and research background but also, in my personal experience, in his communication to each individual patient. He was patient, explained everything and fully understanding of my questions etc. I cannot recommend Dr Nathan enough“
Read more

Subspecialties

  • Advanced Melanoma
  • Skin Cancer
  • Medical Oncology
  • Renal Cancer
Show more

Languages spoken

  • English
Show more

Registered with

  • General Medical Council: 4304959
Show more

    Practices worked at

    LOC - Leaders in Oncology Care

    95 Harley Street, London, United Kingdom, W1G 6AF
    334 reviews

    HCA UK at University College Hospital

    15th Floor University College Hospital 235 Euston Road, London, United Kingdom, NW1 2BU
    156 reviews

    The Wellington Hospital

    St Johns Wood, London, United Kingdom, NW8 7JA
    1,668 reviews

    The Harley Street Clinic

    35 Weymouth Street, london, United Kingdom, W1G 8BJ
    1,783 reviews

    About

    Dr Paul Nathan is an internationally renowned and well-respected Consultant Medical Oncologist with HCA Healthcare at LOC, The Harley Street Clinic, and The Wellington Hospital. His NHS practice is based at Mount Vernon Cancer Centre and UCLH. Dr Nathan’s clinical interests include melanoma of the skin, eye, and internal organs; kidney cancer (renal cell carcinoma), and rare skin cancers including Merkel cell carcinoma.

    He originally trained in cancer immunology as a scientist, and following his Ph.D. and post-doctoral position in Pittsburgh, he ran a tumor immunology laboratory in the pharmaceutical industry. He then pursued clinical studies at Cambridge and UCL.

    Dr Nathan has been a Consultant Medical Oncologist for nearly 20 years. He remains heavily involved in research and is the lead investigator for many clinical trials, particularly in the field of immunotherapy and targeted therapies. Most recently he has led the development of tebentafusp, the first drug proven to improve survival in advanced uveal melanoma. Dr Nathan has published over 100 papers, many of which are in the world’s leading medical journals, and has contributed to a number of medical textbooks. He is the Chair of the UK Uveal Melanoma Guidelines group and the UK Lead for Uveal Melanoma at the International Rare Cancer Initiative. He also leads the melanoma systemic therapies for the European cancer organisation’s (EORTC) melanoma group. Previously, Dr Nathan chaired the NCRI renal cancer clinical studies group. 

     


    Diseases, Medical Tests and Treatments

    • Immunotherapy
    • Chemotherapy
    • Urological Cancer
    • Kidney Cancer
    • Renal Cancer
    • Skin Cancer
    • Melanoma

    Procedures

    • Immunotherapy
    • Chemotherapy
    • Clinical Trials
    Read more

    Special interests

    • Melanoma
    • Advanced Melanoma
    • Skin Cancer
    • Renal (Kidney) Cancer
    • Renal Cancer
    • Urological Cancers
    Read more

    Education

    • PhD
    • FRCP
    Read more

    Insurers

    Powered by Doctify
    Promoting trust & transparency in healthcare